Johnson & Johnson

2 Articles
Participants follow proceedings during the launch of Paliperidone Palmitate for the treatment of schizophrenia. It will be used by adults whose disease has already been stabilized on treatment with paliperidone or risperidone. www.businesstoday.co.ke
FEATURED ARTICLE

Good News: Schizophrenia Medication Approved in Kenya

The Pharmacy and Poisons Board (PPB) has approved the use of Paliperidone Palmitate for the maintenance treatment of schizophrenia in adults. Paliperidone Palmitate will...

FEATURED ARTICLE

Govt partners with Johnson & Johnson on cancer control

The Ministry of Health has stepped up efforts to raise awareness on the National Cancer Control Strategy 2017-2022. Through a series of regional workshops...